Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

NCT00001937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

800

Enrollment

NIH

Sponsor class

Conditions

Aspergillosis
Candidiasis
Fungemia
Mycoses

Interventions

DRUG: FK463
DRUG: Fluconazole

Sponsor

National Cancer Institute (NCI)